Journal of International Reproductive Health/Family Planning ›› 2020, Vol. 39 ›› Issue (2): 153-157.

Previous Articles     Next Articles

Research Progress in the Prevention of Mitochondrial Genetic Diseases by Reproductive Genetic Technology

JI Dong-mei,CAO Yun-xia   

  1. Reproductive Medicine Center,Department of Obstetrics and Gynecology,The First Affiliated Hospital of Anhui Medical University,NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract(Anhui Medical University),Hefei 230032,China
  • Received:2019-12-06 Revised:2020-01-20 Published:2020-03-15 Online:2020-03-15
  • Contact: CAO Yun-xia,E-mail:caoyunxia6@126.com E-mail:caoyunxia6@163.com
  • Supported by:
     

Abstract: Mutations in mitochondrial DNA (mtDNA) that occur in oocytes cause the maternal inherited disorders, known as mitochondrial genetic disease. Mitochondrial genetic diseases usually occur in infants, while most of inherited mtDNA-related diseases affect the function of multiple organs and systems. Therefore, mitochondrial genetic diseases are a series of disabling and fatal diseases that could endanger human health seriously, without effective medical treatment. Those female patients with mitochondrial genetic diseases are not recommended to give birth. Genetic characteristics of mtDNA make the prenatal and pre-pregnancy counseling more difficult for many women with pathogenic mtDNA mutations. The modern reproductive genetic interventions could be considered to reduce the risk of inherited mtDNA-related diseases transmitted to offspring. Preimplantation genetic testing (PGT) and prenatal diagnostic techniques may detect the level of mtDNA mutations, and select normal embryos for transplantation or prevent the birth of offspring with the high levels of mutations. However, these techniques may not be appropriate for all patients. The mitochondrial replacement technique has brought new hope for the prevention of serious inherited mtDNA-related diseases, which is expected to minimize the risk of mtDNA-related diseases in their offspring. The long-term safety and effectiveness should be further studied.

Key words: DNA, mitochondrial;, Mitochondrial genetic diseases;, Genetic diseases, inborn;, Preimplantation genetic testing;Preimplantation diagnosis;, Prenatal diagnosis;, Mitochondrial replacement;, Pronuclear transfer;, Maternal spindle transfer;, Polar body transfer;, Mitochondrial replacement therapy

CLC Number: